PL318501A1 - Pharmaceutic compositions containing a tnc bonding chimeric protein - Google Patents
Pharmaceutic compositions containing a tnc bonding chimeric proteinInfo
- Publication number
- PL318501A1 PL318501A1 PL95318501A PL31850195A PL318501A1 PL 318501 A1 PL318501 A1 PL 318501A1 PL 95318501 A PL95318501 A PL 95318501A PL 31850195 A PL31850195 A PL 31850195A PL 318501 A1 PL318501 A1 PL 318501A1
- Authority
- PL
- Poland
- Prior art keywords
- tnc
- bonding
- compositions containing
- chimeric protein
- pharmaceutic compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94111455 | 1994-07-22 | ||
PCT/EP1995/002788 WO1996003141A1 (en) | 1994-07-22 | 1995-07-15 | Pharmaceutical compositions comprising a chimaeric tnf binding protein |
Publications (1)
Publication Number | Publication Date |
---|---|
PL318501A1 true PL318501A1 (en) | 1997-06-23 |
Family
ID=8216138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL95318501A PL318501A1 (en) | 1994-07-22 | 1995-07-15 | Pharmaceutic compositions containing a tnc bonding chimeric protein |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0772449A1 (en) |
JP (1) | JPH09508140A (en) |
AU (1) | AU3111995A (en) |
BR (1) | BR9508419A (en) |
CA (1) | CA2195665A1 (en) |
CZ (1) | CZ283219B6 (en) |
FI (1) | FI970247A0 (en) |
HU (1) | HUT76666A (en) |
NO (1) | NO970264L (en) |
PL (1) | PL318501A1 (en) |
WO (1) | WO1996003141A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6471956B1 (en) | 1994-08-17 | 2002-10-29 | The Rockefeller University | Ob polypeptides, modified forms and compositions thereto |
US6350730B1 (en) | 1994-08-17 | 2002-02-26 | The Rockefeller University | OB polypeptides and modified forms as modulators of body weight |
US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
US6429290B1 (en) | 1994-08-17 | 2002-08-06 | The Rockefeller University | OB polypeptides, modified forms and derivatives |
US20030040467A1 (en) | 1998-06-15 | 2003-02-27 | Mary Ann Pelleymounter | Ig/ob fusions and uses thereof. |
US6936439B2 (en) | 1995-11-22 | 2005-08-30 | Amgen Inc. | OB fusion protein compositions and methods |
CA2253557A1 (en) * | 1996-05-08 | 1997-11-13 | Louis Martin Renzetti | Treatment of asthma with tnfr-ig |
TW555765B (en) * | 1996-07-09 | 2003-10-01 | Amgen Inc | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins |
US7070771B1 (en) | 1996-12-09 | 2006-07-04 | Regents Of The University Of California | Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
EP0948543A1 (en) * | 1996-12-12 | 1999-10-13 | Genentech, Inc. | Hvem polypeptides and uses thereof |
CA2352363A1 (en) | 1998-11-27 | 2000-06-08 | Synaptics (Uk) Limited | Position sensor |
US7157557B2 (en) * | 2001-02-23 | 2007-01-02 | Immunex Corporation | Increased recovery of active proteins |
WO2003011323A1 (en) * | 2001-07-30 | 2003-02-13 | Genset S.A. | Agonists and antagonists of contabix for use in the treatment of metabolic disorders |
US7786282B2 (en) | 2001-12-06 | 2010-08-31 | The Regents Of The University Of California | Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain |
ATE373503T1 (en) | 2002-02-06 | 2007-10-15 | Ares Trading Sa | TUMOR NECROSIS FACTOR IN COMBINATION WITH INTERFERON IN DEMYELINATING DISEASES |
EP1805320B1 (en) | 2004-10-22 | 2014-09-03 | Amgen Inc. | Methods for refolding of recombinant antibodies |
EP3191131A4 (en) | 2014-08-21 | 2018-09-05 | The General Hospital Corporation | Tumor necrosis factor superfamily and tnf-like ligand muteins and methods of preparing and using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL98078A0 (en) * | 1991-05-07 | 1992-06-21 | Yeda Res & Dev | Pharmaceutical compositions comprising an anticytokyne |
EP0417563B1 (en) * | 1989-09-12 | 2000-07-05 | F. Hoffmann-La Roche Ag | TNF-binding proteins |
GB9015908D0 (en) * | 1990-07-19 | 1990-09-05 | Celltech Ltd | Multivalent immunoglobulin |
JPH07504203A (en) * | 1992-09-15 | 1995-05-11 | イミュネックス・コーポレーション | Method of treating TNF-dependent inflammation using tumor necrosis factor antagonists |
JPH08509203A (en) * | 1992-10-15 | 1996-10-01 | ダナ−ファーバー キャンサー インステテュート インコーポレイテッド | Treatment of obesity-related diabetes type II insulin resistance with antagonists of TNF-α action |
-
1995
- 1995-07-15 PL PL95318501A patent/PL318501A1/en unknown
- 1995-07-15 CA CA002195665A patent/CA2195665A1/en not_active Abandoned
- 1995-07-15 EP EP95926902A patent/EP0772449A1/en not_active Withdrawn
- 1995-07-15 WO PCT/EP1995/002788 patent/WO1996003141A1/en not_active Application Discontinuation
- 1995-07-15 CZ CZ97193A patent/CZ283219B6/en not_active IP Right Cessation
- 1995-07-15 JP JP8505421A patent/JPH09508140A/en active Pending
- 1995-07-15 BR BR9508419A patent/BR9508419A/en not_active IP Right Cessation
- 1995-07-15 HU HU9700180A patent/HUT76666A/en unknown
- 1995-07-15 AU AU31119/95A patent/AU3111995A/en not_active Abandoned
-
1997
- 1997-01-21 NO NO970264A patent/NO970264L/en unknown
- 1997-01-21 FI FI970247A patent/FI970247A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2195665A1 (en) | 1996-02-08 |
CZ19397A3 (en) | 1997-06-11 |
AU3111995A (en) | 1996-02-22 |
NO970264D0 (en) | 1997-01-21 |
FI970247A (en) | 1997-01-21 |
FI970247A0 (en) | 1997-01-21 |
HUT76666A (en) | 1997-10-28 |
BR9508419A (en) | 1997-11-18 |
JPH09508140A (en) | 1997-08-19 |
EP0772449A1 (en) | 1997-05-14 |
WO1996003141A1 (en) | 1996-02-08 |
CZ283219B6 (en) | 1998-02-18 |
NO970264L (en) | 1997-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2398395A (en) | Delayed-release encapsulated warewashing composition | |
PL316040A1 (en) | Pharmaceutic compositions | |
PL318501A1 (en) | Pharmaceutic compositions containing a tnc bonding chimeric protein | |
AU1178995A (en) | Liquid cleaning compositions | |
AU1209295A (en) | Liquid cleaning compositions | |
EP0690122A3 (en) | Detergent compositions | |
EP0754227A4 (en) | Chimeric complement inhibitor proteins | |
AU1559995A (en) | Soldering composition | |
PL320228A1 (en) | Liquid cleaning compositions | |
ZA954521B (en) | Dishwashing compositions | |
AU7263598A (en) | Liquid cleaning compositions | |
AU1894795A (en) | Detergent compositions | |
GB9414105D0 (en) | Liquid detergent compositions | |
AU2866895A (en) | Detergent compositions | |
AU2763395A (en) | Cleaning compositions | |
AU3626989A (en) | Liquid detergent compositions | |
AU1608695A (en) | Liquid cleaning compositions | |
AU6498196A (en) | Liquid cleaning compositions | |
PL324603A1 (en) | Liquid cleaning compositions | |
PL331645A1 (en) | Pharmaceutic composition containing 4-oxobutanic acids | |
AU5074193A (en) | Liquid detergent compositions | |
PL319511A1 (en) | Parenteral pharmaceutic compositions containing gf120918a | |
AU1894695A (en) | Detergent compositions | |
AU1077200A (en) | Novel chimeric polypeptide | |
AU4262889A (en) | Liquid detergent compositions |